IJNS | Free Full-Text | Newborn Screening for Pompe Disease: Pennsylvania Experience
CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy | Genetics in Medicine
A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease - ScienceDirect
A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease - ScienceDirect
Extension of the Pompe mutation database by linking disease‐associated variants to clinical severity - Niño - 2019 - Human Mutation - Wiley Online Library
Treatment approach for IOPD. CRIM, cross-reactive immunologic... | Download Scientific Diagram
CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy | Genetics in Medicine
Preparing for enzyme replacement therapy | Pompe Disease News
![PDF] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/46a41cafff805ae5283a987c04c6c61e6064510d/2-Figure1-1.png "PDF] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. | Semantic Scholar")
PDF] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. | Semantic Scholar
Figure 1 | PLOS ONE
Pompe disease treatment: What are the options? | Pompe Disease News
A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease - ScienceDirect
A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease - ScienceDirect
Verification of CRIM status classification in patients with IOPD. | Download Table
Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel | Italian Journal of Pediatrics | Full Text
A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease - ScienceDirect
Scholars@Duke publication: Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience.
The Clinical Management of Pompe Disease: A Pediatric Perspective
Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants
Clinical and Molecular Disease Spectrum and Outcomes in Patients with Infantile-Onset Pompe Disease - ScienceDirect
PDF) A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease
Frontiers | A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease
Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review. - Abstract - Europe PMC
Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving the Efficacy of ERT | PLOS ONE
